NASDAQ: TXG
10x Genomics Inc Stock Ownership - Who owns 10x Genomics?

Insider buying vs selling

Have 10x Genomics Inc insiders been buying or selling?

Buy
Sell
NameRoleDateSharesPriceValue
Serge SaxonovChief Executive Officer2026-01-0550,000$1.20
$60.00kBuy
Benjamin J. HindsonPresident and Chief Scientific Officer2025-11-248,283$19.00
$157.36kSell
Serge SaxonovChief Executive Officer2025-11-2413,261$19.00
$251.93kSell
Adam TaichChief Financial Officer2025-11-2411,888$19.00
$225.85kSell
Serge SaxonovChief Executive Officer2025-08-229,348$13.79
$128.88kSell
Benjamin J. HindsonPresident and Chief Scientific Officer2025-08-227,486$13.79
$103.21kSell
Adam TaichChief Financial Officer2025-08-2222,315$13.79
$307.66kSell
Serge SaxonovChief Executive Officer2025-05-229,343$8.30
$77.54kSell
Benjamin J. HindsonPresident and Chief Scientific Officer2025-05-227,485$8.30
$62.12kSell
Adam TaichChief Financial Officer2025-05-224,044$8.30
$33.56kSell

1 of 2

TXG insiders have sold more... subscribe to Premium to read more.
Net Insider Buy/Sell (L12M) Ownership

Be the first to know when TXG insiders and whales buy or sell their stock.

TXG Shareholders

What type of owners hold 10x Genomics Inc stock?

Institutional
Insider
Retail
NameHoldSharesValueType
Vanguard Group Inc10.19%13,017,914$245.78MInstitution
Ark Investment Management LLC9.92%12,667,369$239.16MInstitution
Fmr LLC9.33%11,917,482$225.00MInstitution
Blackrock Inc7.84%10,014,462$189.07MInstitution
Paladin Capital Management LLC4.40%5,617,583$106.06MInsider
Sumitomo Mitsui Trust Group Inc4.30%5,492,189$103.69MInstitution
Amova Asset Management Americas Inc4.29%5,486,153$103.58MInstitution
Quantinno Capital Management LP3.65%4,667,203$88.12MInstitution
Bryan E. Roberts3.39%4,336,630$81.88MInsider
Softbank Vision Fund Aiv M2 LP3.00%3,836,232$72.43MInsider

1 of 3

TXG vs Health Information Service Stocks

TickerInst. %Insider %Net Insider (L12M)Net Insider (L3M)
TXG86.48%13.52%Net SellingNet Buying
WGS12.28%87.72%Net SellingNet Selling
HTFL61.41%33.50%Net SellingNet Selling
PRVA45.29%54.71%Net SellingNet Buying
PGNY69.34%30.66%Net SellingNet Selling

10x Genomics Stock Ownership FAQ

Who owns 10x Genomics?

10x Genomics (NASDAQ: TXG) is owned by 96.60% institutional shareholders, 15.11% 10x Genomics insiders, and 0.00% retail investors. Paladin Capital Management LLC is the largest individual 10x Genomics shareholder, owning 5.62M shares representing 4.40% of the company. Paladin Capital Management LLC's 10x Genomics shares are currently valued at $106.06M.

If you're new to stock investing, here's how to buy 10x Genomics stock.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.